高视医疗科技有限公司是一家主要从事眼科医疗器械及耗材的研发、制造及销售的投资控股公司。该公 司经营四个分部。自有产品分部开发及生产手术设备及相关配套软件、内光透镜、眼科疾病诊断及治疗 设备以及相关配套耗材。经销分部销售其他眼科医疗器械制造商生产的多功能诊断设备、眼底诊断、手 术及治疗设备以及相关配套耗材。技术服务分部提供保修服务、维护服务及售后服务所用耗材。其他分 部主要包括授出知识产权权限，以及提供临床研究组织相关服务。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，2月27日南向资金减持3.9万股高视医疗（02407.HK）。近5个交易日中，获南向资金减 持的有5天，累计净减持9.39万股。近20个交易日中，获南向资金减持的有20天，累计净减持26.44万 股。截至目前，南向资金持有高视医疗（02407.HK）558.74万股，占公司已发行普通股的3.77%。 ...

证券之星消息，2月26日南向资金减持1.88万股高视医疗（02407.HK）。近5个交易日中，获南向资金减 持的有5天，累计净减持7.81万股。近20个交易日中，获南向资金减持的有20天，累计净减持22.63万 股。截至目前，南向资金持有高视医疗（02407.HK）562.64万股，占公司已发行普通股的3.8%。 高视医疗科技有限公司是一家主要从事眼科医疗器械及耗材的研发、制造及销售的投资控股公司。该公 司经营四个分部。自有产品分部开发及生产手术设备及相关配套软件、内光透镜、眼科疾病诊断及治疗 设备以及相关配套耗材。经销分部销售其他眼科医疗器械制造商生产的多功能诊断设备、眼底诊断、手 术及治疗设备以及相关配套耗材。技术服务分部提供保修服务、维护服务及售后服务所用耗材。其他分 部主要包括授出知识产权权限，以及提供临床研究组织相关服务。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...

证券之星消息，2月12日南向资金减持7500.0股高视医疗（02407.HK）。近5个交易日中，获南向资金减 持的有5天，累计净减持6.03万股。近20个交易日中，获南向资金减持的有20天，累计净减持21.03万 股。截至目前，南向资金持有高视医疗（02407.HK）564.52万股，占公司已发行普通股的3.81%。 高视医疗科技有限公司是一家主要从事眼科医疗器械及耗材的研发、制造及销售的投资控股公司。该公 司经营四个分部。自有产品分部开发及生产手术设备及相关配套软件、内光透镜、眼科疾病诊断及治疗 设备以及相关配套耗材。经销分部销售其他眼科医疗器械制造商生产的多功能诊断设备、眼底诊断、手 术及治疗设备以及相关配套耗材。技术服务分部提供保修服务、维护服务及售后服务所用耗材。其他分 部主要包括授出知识产权权限，以及提供临床研究组织相关服务。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...

Group 1 - The core point of the article highlights that southbound funds have reduced their holdings in Gaoshi Medical (02407.HK) by 17,000 shares on February 11, with a total net reduction of 61,700 shares over the past five trading days and 203,800 shares over the past 20 trading days [1] - As of now, southbound funds hold 5,652,700 shares of Gaoshi Medical, representing 3.81% of the company's total issued ordinary shares [1] Group 2 - Gaoshi Medical Technology Co., Ltd. primarily engages in the research, development, manufacturing, and sales of ophthalmic medical devices and consumables [1] - The company operates through four segments: self-owned products, distribution, technical services, and others [1] - The self-owned products segment develops and produces surgical equipment and related software, intraocular lenses, diagnostic and treatment equipment for eye diseases, and related consumables [1]

| 交易日 | 持股总数(股) | 持股变动(股) | 变动幅度 | | --- | --- | --- | --- | | 2026-02-10 | 566.97万 | -1.16万 | -0.20% | | 2026-02-05 | 568.13万 | -2.32万 | -0.41% | | 2026-02-03 | 570.45万 | -1000.0 | -0.02% | | 2026-01-29 | 570.55万 | -8900.0 | -0.16% | | 2026-01-27 | 571.44万 | -3800.0 | -0.07% | 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，2月10日南向资金减持1.16万股高视医疗（02407.HK）。近5个交易日中，获南向资金减 持的有5天，累计净减持4.85万股。近20个交易日中，获南向资金减持的有20天，累计净减持19.7万股。 截至目前，南向资金持有高视医疗（02407.HK）566.97万股，占公司已发行普通股的3.82%。 高视医疗科技有限公司是一 ...

Core Viewpoint - Southbound funds have reduced their holdings in Gaoshi Medical (02407.HK) by 23,200 shares on February 5, indicating a consistent trend of net selling over recent trading days [1] Group 1: Southbound Fund Activity - In the past 5 trading days, southbound funds have reduced their holdings for 5 days, with a total net reduction of 42,900 shares [1] - Over the last 20 trading days, southbound funds have reduced their holdings for all 20 days, resulting in a cumulative net reduction of 188,000 shares [1] - Currently, southbound funds hold 5,681,300 shares of Gaoshi Medical, accounting for 3.83% of the company's total issued ordinary shares [1] Group 2: Company Overview - Gaoshi Medical Technology Co., Ltd. is primarily engaged in the research, development, manufacturing, and sales of ophthalmic medical devices and consumables [1] - The company operates through four segments: proprietary products, distribution, technical services, and other services [1] - The proprietary products segment develops and produces surgical equipment, related software, intraocular lenses, and diagnostic and treatment devices for eye diseases [1]

Group 1 - The core point of the article is that southbound funds have reduced their holdings in Gaoshi Medical (02407.HK) by 900 shares on January 8, 2026, marking a trend of consistent reduction over recent trading days [1] - In the last 5 trading days, southbound funds have reduced their holdings for 5 days, with a total net reduction of 93,600 shares [1] - Over the past 20 trading days, there has been a total net reduction of 220,500 shares, indicating a sustained decrease in holdings [1] Group 2 - As of January 8, 2026, southbound funds hold 5.7582 million shares of Gaoshi Medical, which represents 3.88% of the company's total issued ordinary shares [1] - The shareholding changes over the last few trading days show a slight decline, with a maximum reduction of 72,200 shares on December 30, 2025, which corresponds to a 1.23% decrease [2] - Gaoshi Medical Technology Co., Ltd. is primarily engaged in the research, development, manufacturing, and sales of ophthalmic medical devices and consumables, operating through four segments [2]

Group 1 - The core point of the article highlights that southbound funds have reduced their holdings in Gaoshi Medical (02407.HK) by 2,800 shares on December 22, with a total net reduction of 30,700 shares over the last five trading days and 155,200 shares over the last twenty trading days [1] - As of now, southbound funds hold 5,852,700 shares of Gaoshi Medical, which represents 3.95% of the company's total issued ordinary shares [1] Group 2 - Gaoshi Medical Technology Co., Ltd. primarily engages in the research, development, manufacturing, and sales of ophthalmic medical devices and consumables [1] - The company operates through four segments: proprietary products, distribution, technical services, and others [1] - The proprietary products segment develops and produces surgical equipment and related software, intraocular lenses, diagnostic and treatment equipment for eye diseases, and related consumables [1] - The distribution segment sells multifunctional diagnostic equipment, fundus diagnostic, surgical, and treatment equipment produced by other ophthalmic medical device manufacturers, along with related consumables [1] - The technical services segment provides warranty services, maintenance services, and consumables used for after-sales services [1] - The other segment mainly includes granting intellectual property rights and providing clinical research organization-related services [1]

Group 1 - The core point of the news is that Southbound funds have reduced their holdings in Gaoshi Medical (02407.HK) by 2,900 shares on December 9, 2025, marking a continuous trend of reduction over the past trading days [1] - In the last 5 trading days, Southbound funds have cumulatively reduced their holdings by 70,500 shares, while in the last 20 trading days, the total reduction amounts to 151,000 shares [1] - As of now, Southbound funds hold 5,908,200 shares of Gaoshi Medical, which represents 3.99% of the company's total issued ordinary shares [1] Group 2 - Gaoshi Medical Technology Co., Ltd. is primarily engaged in the research, development, manufacturing, and sales of ophthalmic medical devices and consumables [2] - The company operates through four segments: proprietary products, distribution, technical services, and other services, including clinical research organization services [2] - The proprietary products segment develops and produces surgical equipment, related software, intraocular lenses, and diagnostic and treatment equipment for eye diseases [2]